Lipoproteins
Research News and Information

Saturday, November 21, 2009

Prediction of proliferative diabetic retinopathy with hemoglobin level.

30 Oct 2009 OBJECTIVE: To investigate the role of hemoglobin (HGB) level in predicting proliferative diabetic retinopathy (PDR). METHODS: We assessed 426 individuals without PDR at baseline (213 men; 213 women) from the Pittsburgh Epidemiology of Diabetes ... Read more...

The hepatitis C virus and its hepatic environment: a toxic but finely tuned partnership.

10 Oct 2009 Twenty years after its discovery, HCV (hepatitis C virus) still infects 170 million people worldwide and cannot be properly treated due to the lack of efficient medication. Its life cycle must be better understood to develop targeted pharmacological ... Read more...

Syndecan-1 is the primary heparan sulfate proteoglycan mediating hepatic clearance of triglyceride-rich lipoproteins in mice.

29 Sep 2009 Elevated plasma triglyceride levels represent a risk factor for premature atherosclerosis. In mice, accumulation of triglyceride-rich lipoproteins can occur if sulfation of heparan sulfate in hepatocytes is diminished, as this alters hepatic ... Read more...

Latest indexed articles for 'Lipoproteins'

These are the very latest articles for this heading:

• Prediction of proliferative diabetic retinopathy with hemoglobin level. 30 Oct 2009
• Letter by Ala-Korpela et al regarding article, "Lipoprotein particle profiles by nuclear magnetic resonance compared with standard lipids and apolipoproteins in predicting incident cardiovascular disease in women". 25 Oct 2009
• The hepatitis C virus and its hepatic environment: a toxic but finely tuned partnership. 10 Oct 2009
• Syndecan-1 is the primary heparan sulfate proteoglycan mediating hepatic clearance of triglyceride-rich lipoproteins in mice. 29 Sep 2009
• Scavenger receptor class B type I mediates biliary cholesterol secretion independent of ATP-binding cassette transporter g5/g8 in mice. 29 Sep 2009
• Limitations of automated remnant lipoprotein cholesterol assay for diagnostic use. 15 Sep 2009
• Plasma levels of lipoprotein (a) in patients with major depressive disorders. 8 Sep 2009
• Evaluation of antagonistic activities of Bacillus subtilis and Bacillus licheniformis against wood-staining fungi: in vitro and in vivo experiments. 7 Sep 2009
• Kinetic control of TolC recruitment by multidrug efflux complexes. 31 Aug 2009
• Humoral immune response against 38- and 16-kDa mycobacterial antigens in childhood tuberculosis. 30 Aug 2009
• Stimulation of human macrophages (THP-1) using Toll-like receptor-2 (TLR-2) agonist decorated nanocarriers. 30 Aug 2009
• NK cells from tuberculous pleurisy express high ICAM-1 levels and exert stimulatory effect on local T cells. 30 Aug 2009
• Real time analysis of lipoprotein transfer from LolA to LolB by means of surface plasmon resonance. 26 Aug 2009
• A critical role for hemolysins and bacterial lipoproteins in Staphylococcus aureus-induced activation of the Nlrp3 inflammasome. 26 Aug 2009
• Vascular-directed tissue factor pathway inhibitor overexpression regulates plasma cholesterol and reduces atherosclerotic plaque development. 25 Aug 2009
• Photosystem I gene cassettes are present in marine virus genomes. 24 Aug 2009
• Oncogenic Ras, but not (V600E)B-RAF, protects from cholesterol depletion-induced apoptosis through the PI3K/AKT pathway in colorectal cancer cells. 18 Aug 2009
• Cholesterol was healthy in the end. 15 Aug 2009
• A tissue-engineered model of the intestinal lacteal for evaluating lipid transport by lymphatics. 13 Aug 2009
• Genetic evidence for the role of Erk activation in a lymphoproliferative disease of mice. 8 Aug 2009

See a longer list of these articles.

Technical information about 'Lipoproteins'

Definition: Lipid-protein complexes involved in the transportation and metabolism of lipids in the body. They are spherical particles consisting of a hydrophobic core of TRIGLYCERIDES and CHOLESTEROL ESTERS surrounded by a layer of hydrophilic free CHOLESTEROL; PHOSPHOLIPIDS; and APOLIPOPROTEINS. Lipoproteins are classified by their varying buoyant density and sizes. The large lipoproteins (CHYLOMICRONS; VLDL) are to transport triglycerides, and the small lipoproteins (LDL; HDL) are to transport cholesterol.

Registry Number: 0

Descriptor UI: D008074

Alternative terms: Lipoproteins; Circulating Lipoproteins; Lipoproteins, Circulating; Lipoprotein;

Related Mesh Headings: Apolipoproteins; Hyperlipoproteinemias; Hypolipoproteinemias; Lipoid Proteinosis of Urbach and Wiethe; Proteolipids; Receptors, Lipoprotein;

Allowable Qualifiers: administration & dosage; adverse effects; analysis; antagonists & inhibitors; biosynthesis; blood; cerebrospinal fluid; chemical synthesis; classification; deficiency; diagnostic use; drug effects; economics; genetics; history; immunology; isolation & purification; metabolism; pharmacokinetics; pharmacology; physiology; poisoning; radiation effects; secretion; standards; supply & distribution; therapeutic use; toxicity; ultrastructure; urine; chemistry; contraindications; agonists;

Tree Number: D10.532; D12.776.521;

Technical Notes: general or unspecified; prefer specifics; /blood: consider also HYPERLIPOPROTEINEMIA; /defic: consider also HYPOLIPOPROTEINEMIAS & specifics